Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<ArtifactAssessment xmlns="http://hl7.org/fhir">
<id value="179698"/>
<meta>
<versionId value="4"/>
<lastUpdated value="2023-12-06T08:41:24.889Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ArtifactAssessment 179698</b></p><a name="179698"> </a><a name="hc179698"> </a><a name="179698-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 4; Last updated: 2023-12-06 08:41:24+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-adaptation.html">Adaptation</a></p></div><p><b>Artifact Author</b>: Joanne Dehnbostel: </p><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/ArtifactAssessment/179698">https://fevir.net/resources/ArtifactAssessment/179698</a></p><p><b>Artifact Description</b>: </p><div><p>This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data.</p>
</div><p><b>Artifact Status</b>: active</p><p><b>identifier</b>: FEvIR Object Identifier/179698</p><p><b>title</b>: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16</p><p><b>artifact</b>: <a href="Composition-179466.html">Recommendation: ADA Obesity Management Recommendation 8.16</a></p><blockquote><p><b>content</b></p><p><b>informationType</b>: Container</p><p><b>type</b>: <span title="Codes:">adapted element</span></p><p><b>classifier</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 string-datatype}">string Datatype</span></p><p><b>path</b>: overallSummary</p><h3>Components</h3><table class="grid"><tr><td style="display: none">-</td><td><b>InformationType</b></td><td><b>Summary</b></td><td><b>Type</b></td><td><b>Classifier</b></td></tr><tr><td style="display: none">*</td><td>Comment</td><td><div><p>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A</p>
</div></td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 OriginalResourceContent}">Original Resource Content</span></td><td> </td></tr><tr><td style="display: none">*</td><td>Response</td><td> </td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 RationaleForChange}">Rationale for Change to Resource Content</span></td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 suggested-change}">Suggested change</span></td></tr><tr><td style="display: none">*</td><td>Change Request</td><td><div><p>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.</p>
</div></td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 SuggestedChange}">Suggested Change to Resource Content</span></td><td> </td></tr></table></blockquote></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Joanne Dehnbostel"/>
</valueContactDetail>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
<valueUri value="https://fevir.net/resources/ArtifactAssessment/179698"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-description">
<valueMarkdown
value="This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data."/>
</extension>
<modifierExtension
url="http://hl7.org/fhir/StructureDefinition/artifact-status">
<valueCode value="active"/>
</modifierExtension>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="179698"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<title
value="Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16"/>
<artifactReference>🔗
<reference value="Composition/179466"/>
<type value="Composition"/>
<display
value="Recommendation: ADA Obesity Management Recommendation 8.16"/>
</artifactReference>
<content>
<informationType value="container"/>
<type>
<text value="adapted element"/>
</type>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="string-datatype"/>
<display value="string Datatype"/>
</coding>
</classifier>
<path value="overallSummary"/>
<component>
<informationType value="comment"/>
<summary
value="8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A"/>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="OriginalResourceContent"/>
<display value="Original Resource Content"/>
</coding>
</type>
</component>
<component>
<informationType value="response"/>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="RationaleForChange"/>
<display value="Rationale for Change to Resource Content"/>
</coding>
</type>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="suggested-change"/>
<display value="Suggested change"/>
</coding>
</classifier>
</component>
<component>
<informationType value="change-request"/>
<summary
value="8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods."/>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="SuggestedChange"/>
<display value="Suggested Change to Resource Content"/>
</coding>
</type>
</component>
</content>
</ArtifactAssessment>